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Pseudomonas aeruginosa uses the quaternary amine choline as a carbon source, osmoprotectant, and mac-
romolecular precursor. The importance of choline in P. aeruginosa physiology is highlighted by the presence of
multiple known and putative choline transporters encoded within its genome. This report describes the relative
roles of three choline transporters, the ABC transporter CbcXWV and two symporters, BetT1 and BetT3, in P.
aeruginosa growth on choline under osmotic conditions that are physiologically relevant to eukaryotic hosts.
The increased lag phases exhibited by the betT1 and betT1 betT3 mutants relative to the wild type upon
transfer to medium with choline as a sole carbon source suggested roles for BetT1 and BetT3 in cells newly
exposed to choline. BetT3 and CbcXWV, but not BetT1, were sufficient to support growth on choline. betT1 and
betT3 expression was regulated by the repressor BetI and choline, whereas cbcXWV expression was induced by
the activator GbdR and glycine betaine. The data support a model in which, upon transfer to a choline-based
medium, the glycine betaine derived from choline taken up by BetT1 and BetT3 promotes subsequent GbdR-
mediated cbcXWV induction. Furthermore, growth data indicated that the relative contributions of each
transporter varied under different conditions, as BetT1 and CbcXWV were the primary choline transporters
under hypo-osmolar conditions whereas BetT3 was the major choline transporter under hyperosmolar condi-
tions. This work represents the first systematic approach to unravel the mechanisms of choline uptake in P.
aeruginosa, which has the most complex bacterial choline uptake systems characterized to date.
Pseudomonas aeruginosa utilizes the quaternary ammonium
compound (QAC) choline in a variety of biological processes.
Choline can serve as a sole carbon, nitrogen, and energy source
(29). Once inside the cell, choline is catabolized through the
action of BetA and BetB (4) to yield glycine betaine (GB)
which, along with other choline catabolites, can function in the
regulation of genes encoding virulence determinants, including
the hemolytic phospholipase C (PlcH) and phosphorylcholine
phosphatase (PchP) (40). Choline can be used as a potent
osmoprotectant due to its conversion to the compatible solute
GB (8, 10, 27). Choline also serves as a biosynthetic precursor
for phosphatidylcholine (44), a membrane phospholipid often
present in bacteria that form intimate associations with eu-
karyotic hosts (34). The choline derivative phosphorylcho-
line (ChoP) is an important outer surface component for
virulence in several pathogens of the human respiratory
tract (9, 36), and the decoration of surface-exposed Ef-Tu
with ChoP in P. aeruginosa has been implicated in its inter-
action with host cells (3).
P. aeruginosa cannot synthesize choline de novo and thus
must acquire it from its environment. Potential infection sites
in the lungs, urinary tract, skin, and eyes contain choline, and
choline can be derived from abundant host molecules, such as
phosphatidylcholine, acetylcholine, and phosphorylcholine (21,
23, 26, 46, 47). Choline may be similarly plentiful in plants,
some of which also serve as hosts for P. aeruginosa (24), and is
known to be released from plant roots and from dead and
decaying plant and animal tissues (2, 15).
Gram-negative bacteria mainly use two types of transporters
for the uptake of choline and related quaternary amine com-
pounds: the binding protein-dependent ATP-binding cassette
(ABC) transporters and the betaine-choline-carnitine trans-
porters (BCCTs). These are typically energized by ATP and
proton/sodium-motive force, respectively (45, 48). Previously,
we characterized the full set of choline transporters present in
the phytopathogen Pseudomonas syringae. This set includes
one BCCT family transporter, BetT, and two ABC transport-
ers, OpuC and CbcXWV. OpuC and BetT function primarily
in uptake for osmoprotection under hyperosmolar conditions,
whereas CbcXWV functions mainly in uptake for catabolism
under hypo-osmolar conditions. The core CbcWV transporter
components interact not only with CbcX but also with two
additional periplasmic solute binding proteins, BetX and CaiX,
which are encoded elsewhere in the genome and bind GB and
carnitine, respectively (7). Orthologs of the P. syringae BetT,
CbcXWV, and OpuC transporters are highly conserved among
fluorescent pseudomonads, including P. aeruginosa, and ex-
pression of the P. aeruginosa homologs of betT (betT3),
cbcXWV, and opuCA complemented a choline transport-defi-
cient P. syringae strain (6, 7).
Choline uptake in P. aeruginosa is more complex than in P.
syringae due to the presence of not only OpuC (PA14_13580 to
PA14_13600) and CbcVWX (PA14_71000 to PA14_71030),
but also three BCCTs, designated BetT1, BetT2, and BetT3
(PA14_70980, PA14_12990, and PA14_69850, respectively).
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We previously showed that BetT2 and BetT3 transport GB and
choline, respectively, and confer osmoprotection when ex-
pressed in P. syringae in a hyperosmolar environment (6). In
this report, we examine the roles of P. aeruginosa choline
transporters in choline-dependent growth and uptake at an
osmolarity of 280 mOsm/kg/H2O, which is relevant to a mam-
malian host (13). Our results support a model of coordinated
regulation of the expression and activity of CbcVWX, BetT1,
and BetT3. Two transcriptional regulators, the activator GbdR
(40) and the repressor BetI (17), contribute to the control of
transporter expression. In addition, this is the first report char-
acterizing BetT1 activity. We also demonstrate dramatic
changes in the relative contributions of the transporters to
choline uptake at distinct osmolarities. Together, these studies
provide insight into how P. aeruginosa, a pathogen of multiple
species, including animals and plants, acquires choline, partic-
ularly at an osmolarity likely relevant to many tissues in its
eukaryotic hosts (13).
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and
plasmids used in this study are listed in Table 1. The P. aeruginosa and Esche-
richia coli strains were maintained on LB medium at 37°C. A modified morpho-
linepropanesulfonic acid (MOPS) minimal medium (22) that contains 75 mM
NaCl (referred to as MOPS-P) was used to achieve a physiologically relevant
osmolarity, 280 mOsm/kg/H2O (13). 1⁄2-21C medium, with an osmolarity of 95
mOsm/kg/H2O (12), was used as the low-osmolarity medium, and MOPS mini-
mal medium with 750 mM NaCl and an osmolarity of 1,505 mOsm/kg/H2O was
used as a hyperosmolar medium (MOPS-H). Glucose, pyruvate, choline, or GB
was added as the sole source of carbon at 20 mM. Pyruvate or glucose was used
as a carbon source (10, 28) when preparing inocula for growth curve analyses in
media with choline or GB. The osmolality of the medium was determined using
an osmometer (Osmomette A; Precision Systems Inc., Sudbury, MA). When
necessary, antibiotics were used at the following concentrations (in g ml1):
gentamicin (75) and kanamycin (500) for P. aeruginosa and gentamicin (15) and
carbenicillin (75) for E. coli. All liquid cultures were grown at 37°C with vigorous
aeration.
Generation of mutant strains and complementation constructs. In-frame de-
letion constructs for cbcV, betT1, and betT3 were generated using splice overlap
extension (SOE) PCR to amplify and splice the 1-kb regions immediately up-
stream and downstream of each locus. The primers (listed in Table S1 of the
supplemental material) were designed to delete the regions between the first and
last few amino acids of each open reading frame (ORF). The amplified fragment
for each deletion construct was cloned into the pEX18-Gm vector, and the
deletion mutations in P. aeruginosa were obtained by recombination, as described
previously (31). Briefly, the pEX18-Gm constructs were transformed into E. coli
strain S17/pir and then conjugated into the recipient P. aeruginosa strain.
Single-crossover (SCO) derivatives were selected by growth on gentamicin and
were then plated on LB medium containing 5% sucrose with no NaCl to obtain
double recombinants. The various in-frame deletion mutants were identified by
PCR. SCO mutants of betT1 were created by using plasmids based on pMQ89 as
described previously (33). The primers (listed in Table S1 of the supplemental
material) were designed to amplify a 500-bp region within betT1, and the am-
plicon was cloned into pMQ89. Plasmids were propagated in E. coli S17/pir.
The pMQ89 derivatives were conjugated into P. aeruginosa, and SCO mutants
were selected by growth on gentamicin. All of the mutants generated in this study
grew like the parental strain in medium containing pyruvate as the sole carbon
source (see Fig. S3A in the supplemental material). Complementing plasmids for
betT1 were created using the pUCP22 vector (43). To create pBetT1, the original
predicted ORF of betT1 was amplified using primers betT1Fw (5-GTGTTCTT
CGGCTCGACCGC-3) and betT1Rev (5-TCAGGTCTGGTGCTGGGTTGG-
3). To create pBetT1N, which had an alternative start site 54 bp upstream of the
annotated start site, the betT1 ORF was amplified using primers betT1AltFw
(5-ATGAGTACTGCTTCGCCAATA-3) and betT1Rev (5-TCAGGTCTGG
TGCTGGGTTGG-3). The amplicons were cloned into PCR2.1 (Invitrogen),
excised from PCR2.1 by XbaI and HindIII, and ligated into pUCP22.
Growth curve analysis. Strains were grown overnight in MOPS-P medium with
either 20 mM glucose or 20 mM pyruvate as the sole carbon source. Stationary-
phase cultures were centrifuged, and the cell pellets were washed twice with
MOPS buffer and resuspended in an equal volume of the same buffer. The assay
media were inoculated at an initial optical density at 600 nm (OD600) of 0.015
and grown at 37°C with vigorous shaking. Aliquots were taken at the indicated
time points, and the optical densities (OD600) were measured using a spectro-
photometer (Spectramax M2; Molecular Devices, Sunnyvale, CA).
Transport assays. [methyl-14C]choline (specific activity of 55 mCi/mmol) was
obtained from American Radiolabeled Chemicals, Inc. (St. Louis, MO). For the
E. coli MKH13 derivatives, choline uptake was measured in M63 medium (22) as
described previously (5, 6); for P. aeruginosa PA14 derivatives, choline uptake
was similarly evaluated following the transfer of cells from overnight cultures
TABLE 1. Strains and plasmids
Strain or plasmid Description Strain no. Source or reference
P. aeruginosa PA14 strains
WT P. aeruginosa PA14 wild type DH122 25
cbcV In-frame deletion mutant of cbcV DH1578 This study
T1 (betT1) In-frame deletion mutant of betT1 DH1579 This study
T3 (betT3) In-frame deletion mutant of betT3 DH1580 This study
cbcVT1 In-frame deletions of cbcV and betT1 DH1584 This study
cbcVT3 In-frame deletions of cbcV and betT3 DH1581 This study
T1T3 In-frame deletions of betT1 and betT3 DH1583 This study
T1::pMQ betT1::pMQ89 disruption mutant; Gmr DH1593 This study
T3T1::pMQ In-frame deletion mutant of betT3, betT1::pMQ89 disruption mutant; Gmr DH1597 This study
cbcVT3T1::pMQ VT3 with a betT1::pMQ89 disruption mutation; Gmr DH1596 This study
gbdR In-frame deletion of gbdR DH466 42
betI::TnM betTI::TnM; Gmr (mutant ID no. 42999) DH1575 19
Plasmids
pUCP22 High-copy-number Pseudomonas-stabilized vector; Gmr 32
pEX18Gm Integrating vector in P. aeruginosa; Gmr 31
pMQ89 Suicide vector in P. aeruginosa; Gmr 33
pME6041 Broad-host-range vector; Kmr 7
pcbcXWV pME6041 with cbcXWV from P. aeruginosa PAO1; Kmr 7
pbetT3 pME6041 with betT3 from P. aeruginosa PAO1; Kmr 6
pbetT1 pUCP22 with PA14 betT1 ORF as defined by start site in original PAO1/PA14
annotations; Gmr
This study
pbetT1N pUCP22 with PA14 betT1 ORF as defined by alternative upstream start site; Gmr This study
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grown in MOPS-P medium with 20 mM glucose into MOPS-P medium with or
without 20 mM choline as inducer and grown at 37°C for 6 h. The cells were
harvested and the pellets were washed three times in an iso-osmolar buffer, M9
medium (22) without glucose, before resuspension in MOPS-P medium to an
OD600 of 1.0. A 5-l aliquot of [14C]choline (final concentration, 1 mM) was
added to 0.5 ml of cells, followed by shaking for 5 min, and uptake was termi-
nated by centrifugation at 13,000  g. Pellets were washed once with MOPS-P
buffer and resuspended in 2 ml of ScintiVerse BD (Fisher Scientific, Fair Lawn,
NJ). The amount of radiolabel in the cells was determined using a liquid scin-
tillation counter (Tri-Carb liquid scintillation analyzer, model 2100TR; Packard
Instrument Co., Meriden, CT), as previously described (5), and expressed as the
initial uptake rate (in nmol choline/min/mg of protein).
RNA isolation and quantitative real-time PCR. Cells were grown as indicated,
and RNA was isolated using an RNeasy kit (Qiagen). RNA was treated with 2 l
of RQ1 DNase (Promega) for 1 h at 37°C, followed by phenol-cholorform
extraction. The resulting RNA was subjected to PCR to verify the absence of
contaminating DNA and quantified using a Nanodrop spectrophotometer.
cDNA was synthesized using SuperScript III (Invitrogen), 750 ng of starting
RNA, and a 5-NSNSNSNSNS-3 primer instead of random hexamers. The
regimen for cDNA synthesis was 25°C for 5 min, 52°C for 60 min, and 70°C for
15 min. The primers used are listed in Table S1 of the supplemental material.
The PCR regimen was 94°C for 5 min and 40 cycles of 94°C for 30 s, 60°C for 30 s,
and 72°C for 30 s. Quantitative real-time reverse transcription-PCR (qRT-PCR)
was conducted with Power SYBR green and AmpliTaq Gold DNA polymerase
according to the manufacturer’s instructions (Applied Biosystems). The resulting
threshold cycle (CT) values were calculated by using the ABI Prism 7700 se-
quence detection system and analyzed using the relative standard curve method
(for separate tubes) as described in ABI user bulletin no. 2. Briefly, amplification
profiles of each of the primer pairs were generated in duplicate with a 10-fold
dilution series of pooled stock cDNA. A standard curve was generated for each
primer pair by regression analysis as a basis for further quantification of target
transcripts in each sample. The rpoD transcript served as a stable housekeeping
control transcript for all the experiments (30). The induction of mRNA was
determined from the threshold values, which were normalized for rpoD expres-
sion. A dissociation curve step was included at the end of each PCR to verify that
only a single product was amplified.
RESULTS
P. aeruginosa CbcXWV is essential for growth on GB but not
choline at a physiologically relevant osmolarity. To examine
the roles of the P. aeruginosa transporters at an osmolarity that
is likely encountered when living in association with mamma-
lian hosts, we amended MOPS medium with NaCl to an os-
molarity comparable to that of blood and tissue fluids (280
mOsm/kg/H2O), forming MOPS-P (13). In MOPS-P, the PA14
cbcV mutant, which lacks the ATPase required for a func-
tional CbcXWV transporter, did not grow on GB (Fig. 1A),
consistent with our previous observation that the core trans-
porter CbcWV, in association with the periplasmic substrate
binding proteins CbcX and BetX, functions as the major GB
transporter for catabolism-associated uptake (7). In contrast,
the cbcV mutant grew on choline, where it exhibited a longer
lag phase (9 h) relative to the wild type (WT; 4.5 h) (Fig. 1A).
The growth defects of the cbcV strain could be rescued by
genetic complementation with cbcXWV expressed in trans (see
Fig. S1A in the supplemental material). Following initiation
of exponential growth, the doubling time of cbcV was
slightly longer than that of the wild type (3 h versus 2.4 h),
and growth assays using cbcV cells from cultures grown on
choline verified that the delayed growth was not due to
suppressor mutations (data not shown). These data indicate
that one or more transporters in addition to the CbcXWV
transporter contribute to growth on choline at a physiolog-
ically relevant osmolarity.
Despite the fact that choline is converted to GB as it is
catabolized for growth (38, 41), wild-type cells exhibited a
shorter lag phase when grown on choline than on GB as the
sole source of carbon (4 h compared to 6.5 h) (Fig. 1A).
However, after adaptation to the new carbon source, the
growth rates were similar on both compounds. These results
suggest that the initial transport rate for choline is faster than
for GB.
BetT1 and BetT3 contribute to choline acquisition for ca-
tabolism at a physiologically relevant osmolarity. To deter-
mine the full complement of choline transporters in P. aerugi-
nosa that function under physiological conditions, we first
analyzed the expression levels of known and putative QAC
transporters in MOPS-P with glucose alone or glucose with
FIG. 1. Growth curve analysis of PA14 and various transporter
mutants on choline and glycine betaine. (A) Comparison of WT and
cbcV grown in MOPS-P medium amended with 20 mM either choline
(solid lines) or glycine betaine (dashed lines). (B) Comparison of
betT1, betT3, and betT1 betT3 grown in MOPS-P medium
amended with 20 mM choline. (C) Comparison of cbcV, cbcV
betT1, and cbcV betT3 transporter mutants grown in MOPS-P
medium amended with 20 mM choline. Values represent the mean
optical densities at 600 nm from three independent replicates, and
error bars depict the standard deviations. In some cases, the error bars
are obscured by the symbol.
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either choline or GB as the growth substrate (Fig. 2). The cbcV
transcript levels were 15- and 4-fold higher in medium with
choline and GB, respectively, compared to the glucose-only
control cultures (Fig. 2). The betT1 and betT3 transcripts were
induced more than 20-fold in medium with choline compared
to medium with glucose alone or glucose and GB (Fig. 2).
Neither choline nor GB affected levels of betT2 and opuCA
transcripts in MOPS-P medium (Fig. 2).
To characterize the contribution of the BetT1 and BetT3
transporters to growth, we tested the growth kinetics of betT1
and betT3 strains in MOPS-P medium with choline. betT1
cultures showed a longer lag than the wild type (Fig. 1B) but
achieved a similar growth rate and final yield (Fig. 1B). The
same phenotype was observed in a betT1 insertional mutant,
betT1::pMQ89 (see Fig. S2 in the supplemental material), sug-
gesting that this reduced growth on choline was not a result of
an unintended deletion of promoter elements of the diver-
gently transcribed betIBA locus, which encodes the genes in-
volved in choline catabolism. These results suggest that BetT1
is involved in choline uptake in PA14 under physiologically
relevant conditions. However, repeated attempts to comple-
ment the P. aeruginosa betT1 growth phenotype with a plasmid
expressing the structural betT1 gene from PAO1 as identified
in the original annotation (18) were unsuccessful. Further-
more, P. syringae GB4, a strain deficient in choline uptake, did
not result in any choline uptake activity under low-salt (C.
Chen and G. A. Beattie, unpublished data) or high-salt condi-
tions (6). This apparent contradiction prompted us to evaluate
whether the published ORF for betT1 was annotated correctly.
Sequence analysis showed that the N-terminal amino acid se-
quence of PA5375 (BetT1) lacked 18 amino acids that were
present in closely related homologs (accession numbers
YP_002875176, NP_795000, and YP_001666502); moreover, a
potential alternative start site was found 54 bp upstream of the
annotated start site. To evaluate if these additional 18 amino
acids are required for an active form of BetT1, we cloned both
ORFs and expressed them in E. coli MKH13 (14), which is
deficient in choline uptake. A clone expressing betT1 from the
alternative start site (pbetT1N) was able take up [14C]choline
in M63 medium with an osmolarity comparable to MOPS-P
(5.0  1.4 nmol/mg of protein in 10 min), whereas a clone
expressing betT1 (pbetT1) was not (0.02  0.01 nmol/mg of
protein in 10 min).
When BetT1 (from pbetT1N) was expressed in MKH13,
activity was detected even in a minimal medium lacking so-
dium amendment (data not shown), consistent with proton
rather than sodium symport activity, as observed for other
BCCT choline transporters (48). Furthermore, BetT1 uptake
activity decreased in experiments in which the osmolarity of
the assay buffer was increased by increments of 0.2 M NaCl
(data not shown). No increase in uptake rate was observed as
the choline availability increased from 10 M to 1 mM (data
not shown), suggesting that BetT1 is a low-capacity choline
transporter, unlike the exceptionally high capacity of P. syrin-
gae BetT (6). BetT1 also appears to be a high-affinity trans-
porter, based on its ability to take up a significant amount of
choline (5 nmol/mg of protein in 10 min) when MKH13 cells
expressing betT1 are provided with only 10 M [13C]choline;
this is in comparison to our previous finding of low-affinity
transport by the P. syringae BetT transporter (6).
Unlike the delayed growth observed for betT1 cultures, a
betT3 strain was not altered in growth compared to the wild
type (Fig. 1B). To further analyze the relative roles of
CbcXVW, BetT1, and BetT3 in choline transport, we made a
series of double and triple mutants (listed in Table 1) and
assessed their growth in medium with choline. The betT1
betT3 mutant showed a longer lag and grew at a slightly lower
rate than the WT and single betT1 and betT3 mutants (Fig.
1B). Genetic complementation with betT1 (pbetT1N) (see Fig.
S1B in the supplemental material) or betT3 (see Fig. S1C)
expressed in trans restored the phenotype of the betT1 betT3
mutant to that of the relevant single mutants. The longer lag
phase of the double mutant indicated that both BetT1 and
BetT3 contribute to the early uptake of choline, i.e., to its
uptake during the lag phase following a shift to choline as a
carbon source, since the betT1 betT3 mutant exhibited a
more profound defect in initiation of growth on choline than
either single mutant.
To better assess the activities of BetT1 and BetT3 during
growth on choline, the betT1 and betT3 genes were also deleted
in a cbcV background. The cbcV betT1 double mutant
exhibited a longer lag and slower growth rate (doubling time of
3 h), similar to that of the cbcV mutant (Fig. 1C). However,
the cbcV betT3 mutant failed to grow with choline as the
sole source of carbon even by 22 h (Fig. 1C), as did a triple
mutant lacking all three transporters (see Fig. S2 in the sup-
plemental material). All of the single and double mutants grew
like the wild type in minimal medium with pyruvate, indicating
that the defects are specific to choline uptake (see Fig. S3A in
the supplemental material). These data suggest that the growth
on choline observed in the cbcV mutant background depends
on BetT3 and not BetT1. Collectively, these studies show that
CbcXWV, BetT1, and BetT3 can all contribute to choline
uptake for catabolism under physiologically relevant osmolar-
ities, but they also show that BetT1 is distinguished by its
inability to support growth when CbcXWV and BetT3 are both
absent (Fig. 1C), possibly due to a low transport capacity, its
undetectable contribution to growth when CbcXWV and
BetT3 are both present (Fig. 1B), and its ability to partially
compensate for the loss of BetT3 when CbcXWV is present.
FIG. 2. qRT-PCR analysis of expression of QAC transporters in
the presence of choline and GB. The strains were grown in MOPS-P
medium with 20 mM glucose and 10 mM choline or GB for 5.5 h.
Medium without any quaternary ammonium compounds served as the
control condition. The qRT-PCR data represent the means obtained
from biological duplicates. Expression levels are shown relative to
levels of the housekeeping gene rpoD. All ratios were normalized to
expression levels in medium without QAC (set to 1). Error bars are the
standard deviations.
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Both BetT1 and BetT3 contribute to early uptake of choline.
The lengthened lag phases of the betT1 and betT1 betT3
mutants following transfer to choline (Fig. 1B) suggest that
their activities contribute to the acquisition of choline during
this period. To evaluate this hypothesis, we measured the up-
take rates of [14C]choline, with and without 6 h of preinduction
with choline, of the various mutants in MOPS-P. In uninduced
cells provided with a high concentration of choline (1 mM),
choline uptake was significantly reduced in mutants lacking a
functional betT3 gene (Fig. 3). Furthermore, the lack of a
difference between the double (betT1 betT3) or triple
(cbcV betT3 betT1::pMQ89) mutants and the betT3 single
mutant suggests that BetT3 was the major contributor to cho-
line transport in uninduced cells under these conditions (Fig.
3). In cells incubated in medium with choline for 6 h, which
would support induction of betT1, betT3, and cbcXWV tran-
scription (Fig. 2), but prior to rapid growth on choline in
wild-type cultures (Fig. 1), the wild type showed a 4-fold in-
crease in choline transport activity (Fig. 3). Choline transport
was decreased by 52% and 80% in the betT1 and betT3
mutants, respectively, and by 90% in the betT1 betT3 mu-
tant and triple mutant (Fig. 3). The cbcV mutant did not show
a decrease in initial uptake rate of choline relative to the wild
type under either condition (Fig. 3). These data show that
basal choline uptake and early uptake after exposure to choline
was primarily due to the activities of BetT1 and BetT3. We
predict that the activities of BetT1 and BetT3 contribute to a
subsequent increase in CbcXWV activity, either through in-
creased cbcXWV transcription or CbcXWV activity, and this
hypothesis is tested in the experiments described below.
cbcXWV transcription is controlled by GbdR in response to
GB. To evaluate the effects of BetT1 and BetT3 activity on
cbcXWV expression, we investigated cbcXWV regulation. The
cbcXWV genes are near the gene encoding the transcriptional
regulator GbdR (see Fig. S4A in the supplemental material).
We have previously demonstrated that GbdR, an AraC family
transcription factor, is required for GB-induced expression of
the phospholipase C gene plcH, the choline phosphatase gene
pchP, and the GB catabolic genes through direct DNA binding
to a GbdR box (40, 42). Analysis of the promoter region of
cbcXWV revealed the presence of a GbdR recognition se-
quence (40) upstream of the cbcXWV genes (see Fig. S4A). To
determine if GbdR regulated cbcXWV induction, the transcript
levels of cbcV were analyzed in the wild-type and gbdR mu-
tant backgrounds after growth in medium with glucose alone
or glucose and choline. Glucose was added to the medium to
promote similar growth by the mutant strains and the wild
type; glucose is known not to repress glycine betaine use via
catabolite repression (10). cbcV expression in the wild type was
induced over 15-fold by choline and was over 15-fold higher
than in the gbdR mutant (Fig. 4). These data suggest that the
cbcXWV operon is part of the GbdR regulon. In contrast,
transcript levels of betT1 and betT3 were largely unaffected
when gbdR was inactivated; that is, although they were induced
26- and 22-fold by choline, respectively, they were only 2-fold
higher in the wild type than the gbdR mutant (Fig. 4). These
results suggest that GbdR regulates the expression of cbcXWV
but not betT1 and betT3.
Expression of betT1 and betT3 is derepressed by BetI in
response to choline. Similar to the genomic context of its
homologs in E. coli and Sinorhizobium meliloti, betT1 is tran-
scribed divergently from the betIBA genes (see Fig. S4B); in E.
coli, BetI encodes a transcriptional repressor of both betT and
betIBA (4, 16). The analysis of the P. aeruginosa betT1 pro-
moter performed by Velasco-Garcia et al. (39) revealed a
possible BetI binding site at bp 187 (see Fig. S4B). Analysis
of the promoter region of betT3 also revealed the presence of
a BetI binding site at bp 79 (see Fig. S4B). To determine if
the BetI repressor regulates betT1 and betT3 expression, the
transcript levels of betT1 and betT3 were analyzed in the
betI::TnM mutant background in a medium with choline. betT1
and betT3 mRNA levels were more than 20- and 5-fold higher,
respectively, in the betI mutant than in wild-type cells (Fig. 4).
The expression of cbcV was only slightly reduced in a betI
mutant (	2-fold) (Fig. 4). These data suggest that betT1 and
betT3 expression levels are repressed by BetI and that choline
promotes derepression.
FIG. 3. BetT1 and BetT3, but not CbcXWV, are involved in early
choline uptake. Uptake of 1 mM [14C]choline by P. aeruginosa PA14
and various mutants is shown. Cells were grown in MOPS-P, incubated
for 6 h in the presence or absence of 20 mM choline as an inducer,
washed three times in an isomolar medium (M9 without glucose), and
evaluated for uptake in MOPS-P containing 20 mM glucose in a 5-min
assay. Black bars represent uninduced cultures, and white bars repre-
sent cultures preinduced with choline. Values are mean initial uptake
rates  standard errors of the means (n 
 3 or 6).
FIG. 4. Regulation of expression of P. aeruginosa choline trans-
porter genes. qRT-PCR analysis of expression of cbcV, betT1, and
betT3 in WT, gbdR, and betI::TnM in MOPS-P medium with 20 mM
glucose and 10 mM choline after 5.5 h of growth. Medium without any
quaternary ammonium compounds served as the control condition.
The expression levels were normalized to rpoD transcript levels and
are presented as the fold induction compared to levels in the absence
of choline. Values are the means of biological duplicates  the stan-
dard deviations.
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To determine if uptake of choline by BetT1 and BetT3 and
the subsequent conversion of choline to GB enhanced the rate
of cbcXWV induction following exposure to choline, we ana-
lyzed the transcript levels of the cbcV gene in wild-type and
betT1 betT3 cells upon transfer from medium with pyruvate
as the sole source of carbon to a medium with choline as the
growth substrate. At 3.5 h after transfer, the wild-type and
betT1 betT3 mutant cultures were at the same density and
were just exiting the lag phase (Fig. 5B). At this time, as shown
in Fig. 5A, the transcript levels of cbcV had increased 75-fold
in the wild type but only 15-fold in the betT1 betT3 mutant,
indicating that BetT1 and BetT3 enhanced cbcXWV induction
by choline. The relative levels of cbcV expression decreased to
levels comparable to those in the betT1 betT3 mutant at
5.5 h after transfer into the medium with choline (Fig. 5A),
perhaps due to the consumption of inducing compounds, such
as GB and dimethylglycine, during catabolism (42).
To evaluate if BetT1 and BetT3 contributed to the induction
of the cbcXWV genes, we determined if pregrowth on GB, the
inducing ligand of GbdR, would be sufficient to eliminate the
differences in lag phase between the wild type and the betT1
betT3 mutant. As shown in Fig. 5B, the delay in growth of
betT1 betT3 was abolished when the cells were preinduced
with GB. Furthermore, after 3.5 h with GB rather than choline
as a preinducer, cbcV transcript levels were similar in the wild
type and the betT1 betT3 mutant, with the mutant having
cbcV transcript levels that were 82  1.8% (mean  standard
deviation) of those in the wild type in GB but only 5% of
those in the wild type in choline (Fig. 5A).
Modulating osmolarity alters the relative roles of the trans-
porters for uptake of choline for catabolism. Previously, P.
aeruginosa has been shown to utilize choline as a sole carbon
source under conditions of hypo- and hyperosmolarity (20). To
gain better insight into the relative role of the transporters
under the various conditions that P. aeruginosa might encoun-
ter, we examined growth of the various mutants on choline in
hyper- and hypo-osmolar media. Growth assays showed that
BetT3 plays a major role in growth on choline in hyperosmolar
medium (MOPS-H) based on the finding that the wild type and
betT1 and cbcV mutants all had similar growth kinetics, a
9-h lag phase, and a doubling time of 3.4 h, whereas the betT3
and betT3 cbcV mutants were severely compromised in
growth (Fig. 6A). In MOPS-H, choline is also used by P.
aeruginosa as an osmoprotectant (see Fig. S3B in the supple-
mental material). The wild type and all of the mutants, includ-
ing a triple mutant that lacks betT1, betT3, and cbcV, were able
to use choline as an osmoprotectant in this medium (see Fig.
S3B), demonstrating that other transporters contribute to P.
aeruginosa osmoprotection.
In hypo-osmolar medium with choline, the cbcV mutant
failed to grow and the betT1 mutant had a longer lag phase
(5.4 h) and a slower growth rate (5.4 h) (Fig. 6B). In contrast,
the betT3 mutant grew like the wild type, having a lag phase
of 2 h and a doubling rate of 2.6 h (Fig. 6B), while the betT1
betT3 strain resembled betT1 in its growth kinetics (Fig. 6B).
Based on these results, choline uptake under hypo-osmolar
conditions is due to the activity of CbcXWV and BetT1.
DISCUSSION
Our results demonstrate distinct roles for three P. aeruginosa
choline transporters in supporting cellular growth on choline.
These transporters differ in their contribution to growth not
only at distinct osmolarities but also at different times follow-
ing exposure to choline. In particular, immediately following
the transfer of cells to conditions requiring choline catabolism
at an osmolarity relevant to mammalian host tissues, the BetT1
and BetT3 transporters had the primary role in adaptation
during the lag phase. Following adaptation, however, the
CbcXWV transporter became increasingly important in its
contribution to growth, while BetT1 and BetT3 diverged in
their relative activities. Our results are consistent with the
following model for the regulation and roles of these trans-
porters in choline uptake for catabolism at a physiologically
relevant osmolarity (Fig. 7). In cells that have not been induced
by choline, the basal activities of BetT1 and BetT3 are higher
than that of CbcXWV; thus, following exposure to choline,
these transporters are primarily responsible for the initial
choline uptake. The transported choline increases the ex-
pression of the betT1 and betT3 genes, at least in part via
FIG. 5. Contributions of BetT1 and BetT3 to cbcV expression in
PA14. (A) qRT-PCR analysis of expression of cbcV in the wild type
and betT1 betT3. The strains were grown in MOPS-P medium
amended with 20 mM choline, and RNA was extracted from aliquots
removed at the indicated time points. Expression levels were normal-
ized to rpoD transcript levels and are presented as the fold induction
compared to levels in the WT at 0 h (uninduced). Values are the mean
fold induction of biological duplicates  the standard deviation.
(B) Comparison of PA14 and betT1 betT3 grown in MOPS-P me-
dium amended with 20 mM choline. The cells were pregrown in me-
dium with pyruvate (solid lines) or glycine betaine (dashed lines).
Values are mean optical densities at 600 nm (n 
 3).
FIG. 6. Growth curves of PA14 and various mutants on choline-
containing media with high and low osmolarities. (A) Strains grown in
hyperosmolar MOPS-H medium with 20 mM choline. (B) Strains
grown in hypo-osmolar 1⁄2-21C medium with 20 mM choline. Values
represent the mean optical densities at 600 nm from two independent
replicates, and error bars, where visible, depict the standard deviations.
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derepression of the betT1 and betT3 genes by BetI. The
transported choline is converted to GB, which is an activat-
ing ligand for the transcriptional factor GbdR (40) to in-
crease expression of cbcXWV. Lastly, as CbcXWV-mediated
uptake increases, the relative contributions of BetT1 and
BetT3 to uptake decrease, with the contribution of BetT1
decreasing to undetectable levels.
Several lines of evidence support a role for BetT1 and BetT3
in the initial induction of cbcXWV expression. First, the induc-
tion of cbcV in cells following transfer to a choline-based me-
dium was delayed in the betT1 betT3 mutant relative to the
wild type (Fig. 5A), consistent with a need for BetT1 and
BetT3 during the initial adaption to this medium. Second, the
lengthened lag period of the betT1 betT3 cells following
transfer to a choline-based medium was significantly shortened
by prior exposure to GB (Fig. 5B), consistent with early
cbcXWV expression compensating for a BetT1/BetT3 defi-
ciency. Third, measurements of the initial uptake rate of
[14C]choline showed that CbcXWV exhibited little uptake ac-
tivity in the absence of choline induction relative to the activity
in its presence (Fig. 3).
We found that BetT1 and BetT3, which share 53% identity
in amino acid sequence, exhibit distinct characteristics. For
example, at a physiologically relevant osmolarity, BetT3 was
sufficient for growth on choline in a cbcV mutant background,
whereas BetT1 was not (Fig. 1C). Transport assays also sug-
gested greater uptake activity for BetT3 than BetT1 under
these conditions (Fig. 3). Despite the greater contribution of
BetT3 to growth, loss of BetT1, but not BetT3, resulted in a
detectable lengthening of the lag phase following transfer to a
choline-based medium. This may reflect a more rapid increase
in betT1 expression in the presence of choline, although this
has not yet been tested. BetT1 and BetT3 also differ in their
response to external osmolarity, with BetT1 as well as
CbcXWV serving as the major transporters contributing to
growth on choline in a hypo-osmolar environment (Fig. 6B)
and BetT3 as the dominant transporter during growth on cho-
line in a hyperosmolar environment (Fig. 6A). Previously, we
showed that choline uptake by P. syringae BetT, which is 53%
and 79% identical to BetT1 and BetT3, respectively, increases
with increasing osmolarity and that both osmoregulation and
activity in high-salt environments depend on the presence of a
C-terminal tail (6). Domain analysis of E. coli BetT also dem-
onstrated the importance of the C-terminal tail for the osmo-
regulation of transport activity (37). The fact that BetT3 is salt
activated (5) but BetT1 is not (data not shown) may be due to
the fact that BetT1 lacks the cytoplasmic C-terminal tail, which
follows the 12th transmembrane helix in P. syringae BetT and
P. aeruginosa BetT3. The absence of the osmoregulatory tail
may make P. aeruginosa BetT1 into a transporter that no lon-
ger requires salt for activation but with lower activity than
BetT3. Our finding that cbcV betT1 still grows with choline
as the sole source of carbon in a medium at a physiologically
relevant osmolarity but cbcV betT3 cannot grow (Fig. 1C) is
consistent with BetT1 having a lower transport activity.
Luchessi et al. (20) demonstrated that P. aeruginosa can
grow on choline in a high-salt medium, and here we identified
BetT3 as the key transporter involved in growth on choline
under hyperosmolar conditions (Fig. 6A). It is not yet clear
why other transporters involved in osmoprotection, such as the
OpuC transporter (5), or catabolism, such as CbcXWV, do not
support growth at high osmolarity (Fig. 6A). The OpuC trans-
porter has been shown to transport choline for osmoprotection
in P. syringae (5). Although the cbcV betT3 betT1::pMQ89
triple mutant is defective in using choline as a carbon source
(see Fig. S2 in the supplemental material), it is only slightly
impaired in its ability to use choline as an osmoprotectant (see
Fig. S3B in the supplemental material), suggesting a role for
the P. aeruginosa OpuC homolog (PA3888 to -3891) in osmo-
protection. Based on the low-capacity transport activity dem-
onstrated by the P. syringae OpuC transporter (5), we propose
that OpuC-mediated transport is not sufficient to support
growth based on choline catabolism. In contrast, the CbcXWV
transporter likely does not support growth at high osmolarity
because of its inhibitory effects on CbcXWV activity, such as
on the choline binding to the periplasmic binding protein or
protein-protein interactions, or on the expression of cbcXWV.
A previous study demonstrated that hyperosmolarity inhibits
the activity of various ABC transporters (11).
Previously, we described the role of the GbdR transcription
factor and its ligand GB in the transcriptional regulation of
FIG. 7. Model of the regulation and roles of the P. aeruginosa
choline transporters in an environment with an osmolarity that is
physiologically relevant to a eukaryotic host. (A) Choline promotes
expression of betT1, betT3, and cbcXVW. Increased expression in re-
sponse to choline and GB is dependent on the regulators BetI and
GbdR, respectively, and choline is converted into GB by BetAB (1).
(B) Following cellular exposure to an abundance of choline (e.g., 1
mM), the initial transport depends primarily on BetT1 and BetT3, with
BetT1 initially contributing more than BetT3, possibly because of
higher BetT1 protein levels in uninduced cells. (C) Adaption to the
presence of abundant choline involves increasing expression of betT1
and betT3, as shown in panel A, with increasing choline uptake pro-
moting the induction of cbcXWV. The contribution of CbcXWV to the
total choline uptake increases as its protein levels increase, while the
contribution of BetT3 relative to BetT1 increases due to the greater
transport capacity of BetT3 (Fig. 3). Growth data indicated that either
BetT3 or CbcXWV is sufficient for robust growth with choline as the
sole carbon source. (D) Exposure of cells to abundant GB prior to
choline greatly increases the contribution of CbcXWV to choline
transport due to cbcXWV induction, and this circumvents the major
roles for BetT1 and BetT3 in transport immediately following expo-
sure to choline. OM, outer membrane; IM, inner membrane.
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phospholipase C (plcH), phosphorylcholine phosphatase
(pchP), and multiple genes involved in GB catabolism (40, 42).
Here, we showed that cbcXWV is part of the GbdR regulon
and that under conditions predicted to be relevant to host
tissues, cbcXWV expression required BetT1 and BetT3 uptake
to provide the GB coinducer for GbdR-mediated regulation.
Thus, we predict that the uptake of choline by BetT1 and
BetT3 is important in vivo. A recent microarray study by Son et
al. investigating expression profiles of P. aeruginosa genes in
sputum from cystic fibrosis patients showed high expression
levels of transporter genes betT1 and betT3 genes along with
the cbcXWV operon. In fact, the study found these choline
transporter genes to be among the most highly expressed genes
in the cystic fibrosis patient sputum, along with genes encoding
lipases, amino acid and fatty acid degradation enzymes, and
the betIBA operon, which is involved in conversion of choline
to GB (35). This supports the hypothesis that choline is actively
acquired during lung infections and that these transporters
play an important role in colonization of the lungs. A complete
understanding of choline uptake and the utilization of mutants
unable to acquire choline in pathogenesis models will allow us
to determine the importance of this abundant resource for P.
aeruginosa virulence.
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